Ivor Royston, Director at Syndax Pharmaceuticals Inc (SNDX), bought 236,419 shares at $12.00 ($1.8M) on 2016-03-08, disclosed to the SEC on 2016-03-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 86,419 | $0 | 0.0% |
| 2 | $12.00 | 150,000 | $1.8M | 100.0% |
| Total | $7.61 avg | 236,419 | $1.8M | 100% |
| Filing → |
| VIRX | SELL | 2022-03-01 | $41K | — | Filing → |
| VIRX | BUY | 2021-11-15 | $44K | — | Filing → |
| BIOC | BUY | 2017-03-29 | $50K | — | Filing → |